Bridger Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-588,910
| Closed | -$15.1M | – | 50 |
|
|
2021
Q1 | $15.1M | Buy |
+588,910
| New | +$15.1M | 1.41% | 27 |
|
|
2020
Q4 | – | Sell |
-503,012
| Closed | -$9.05M | – | 43 |
|
|
2020
Q3 | $9.05M | Sell |
503,012
-970,556
| -66% | -$17.5M | 0.72% | 32 |
|
|
2020
Q2 | $37.4M | Sell |
1,473,568
-205,776
| -12% | -$5.23M | 3.47% | 12 |
|
|
2020
Q1 | $30.9M | Sell |
1,679,344
-302,289
| -15% | -$5.55M | 3.57% | 15 |
|
|
2019
Q4 | $43.7M | Sell |
1,981,633
-676,563
| -25% | -$14.9M | 3.15% | 16 |
|
|
2019
Q3 | $38.2M | Sell |
2,658,196
-1,512,869
| -36% | -$21.7M | 3.15% | 15 |
|
|
2019
Q2 | $65.7M | Sell |
4,171,065
-602,653
| -13% | -$9.49M | 5.16% | 5 |
|
|
2019
Q1 | $69.9M | Hold |
4,773,718
| – | – | 5.54% | 3 |
|
|
2018
Q4 | $51M | Sell |
4,773,718
-756,310
| -14% | -$8.08M | 4.25% | 7 |
|
|
2018
Q3 | $84.4M | Buy |
5,530,028
+2,304,501
| +71% | +$35.2M | 4.88% | 6 |
|
|
2018
Q2 | $39.5M | Buy |
3,225,527
+1,998,707
| +163% | +$24.5M | 2.14% | 22 |
|
|
2018
Q1 | $11.7M | Buy |
1,226,820
+320,822
| +35% | +$3.07M | 0.71% | 33 |
|
|
2017
Q4 | $8.18M | Buy |
+905,998
| New | +$8.18M | 0.54% | 32 |
|